↓ Skip to main content

Quetiapine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

policy
1 policy source
twitter
10 tweeters

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
120 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Quetiapine for schizophrenia
Published in
Cochrane database of systematic reviews, April 2004
DOI 10.1002/14651858.cd000967.pub2
Pubmed ID
Authors

Manit Srisurapanont, Benchalak Maneeton, Narong Maneeton, Sudheer Lankappa, Rahul Gandhi

Abstract

Quetiapine is an atypical antipsychotic with, theoretically, a low propensity for movement disorder adverse effects. It is used for the treatment of schizophrenia and other psychoses.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 119 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 19%
Researcher 16 13%
Student > Doctoral Student 12 10%
Student > Ph. D. Student 11 9%
Other 11 9%
Other 29 24%
Unknown 18 15%
Readers by discipline Count As %
Medicine and Dentistry 40 33%
Psychology 19 16%
Nursing and Health Professions 11 9%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 12 10%
Unknown 27 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2017.
All research outputs
#2,675,004
of 15,827,677 outputs
Outputs from Cochrane database of systematic reviews
#5,398
of 11,293 outputs
Outputs of similar age
#20,463
of 126,365 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 97 outputs
Altmetric has tracked 15,827,677 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,293 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.5. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 126,365 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.